![](../../files/images/goods/81069-02-5.png)
DTSSP Crosslinker
CAS No. 81069-02-5
DTSSP Crosslinker ( —— )
产品货号. M26673 CAS No. 81069-02-5
DTSSP Crosslinker 是一种可裂解的 ADC 连接体,可用于合成抗体药物偶联物 (ADC)。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥405 | 有现货 |
![]() ![]() |
5MG | ¥543 | 有现货 |
![]() ![]() |
10MG | ¥770 | 有现货 |
![]() ![]() |
25MG | ¥1353 | 有现货 |
![]() ![]() |
50MG | ¥1968 | 有现货 |
![]() ![]() |
100MG | ¥2811 | 有现货 |
![]() ![]() |
200MG | ¥4188 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称DTSSP Crosslinker
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述DTSSP Crosslinker 是一种可裂解的 ADC 连接体,可用于合成抗体药物偶联物 (ADC)。
-
产品描述DTSSP Crosslinker is a cleavable ADC linker and can be used to synthesize antibody-drug conjugates (ADCs).(In Vitro):The ADCs consist of an antibody to which the ADC cytotoxin is attached via an ADC linker .
-
体外实验ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Human Endogenous Metabolite| Microbial Metabolite
-
研究领域——
-
适应症——
化学信息
-
CAS Number81069-02-5
-
分子量564.52
-
分子式C14H16N2O14S4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOS(=O)(=O)C1CC(=O)N(OC(=O)CCSSCCC(=O)ON2C(=O)CC(C2=O)S(O)(=O)=O)C1=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Gryp T, et al. p-Cresyl Sulfate. Toxins (Basel). 2017 Jan 29;9(2).
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
Shield-1
Shield-1 是 FK506 结合蛋白 12 (FKBP) 的特异性、高亲和力和细胞渗透性配体,通过与突变的 FKBP (mtFKBP) 结合来逆转不稳定性,从而允许 mtFKBP 融合蛋白的条件表达。 Shield-1可以稳定整个融合蛋白。
-
coreopsin
Coreopsin是金鸡菊的主要成分之一。花(CTF)。 用于治疗高血压和糖尿病以及降低体重和血脂。
-
1-O-Acetyl britannil...
1-O-Acetyl britannilactone shows antifungal, and anti-cancer activities, it suppresses angiogenesis and lung cancer cell growth possibly via regulating the VEGFR-Src-FAK signaling.